Abstract:Objective The association of high-sensivity C-reactive protein (hs-CRP) on patients undergoing percutaneous coronary intervention (PCI) and the long-term prognostic value were evaluated.Methods A prospective cohort study was prospectively conducted in 287 consecutive patients who were hospitalized in the Department of Cardiology of Shanghai Zhongshan Hospital undergoing primary PCI between Dec.2007 and Dec.2008.Levels of hs-CRP and other cardiovascular risk factors were determined before PCI.The patients were followed up for a mean of 54 months.Their cardiovascular end points were recorded.Results The mean value of serum hs-CRP in patients with cardiovascular disease (CVD) readmission and death was significantly higher than those without CVD readmission and death (2.21 mg/L versus 1.10 mg/L,Z=-3.152;6.60 mg/L versus 1.22 mg/L,Z=-3.192;P both ＜0.05).The cardiac troponin T,WBC,multivessel disease,stent placement and the low HDL-C are the factors relating to serum hs-CRP levels.The coefficients of correlation have statistical significance (t =8.575,4.763 and -2.770;P ＜0.05).The odd ratios for CVD readmissiom and CVD death were 1.714(95％ CI,1.164-2.523)and 5.023 (95 ％ CI,2.003-12.600).Kaplan-Meier survival analysis demonstrated a significantly reduced 5-year readmission rate in patients with 3.65 ＜ hs-CRP ≤ 82.51 mg/L [43.75％ (30/71) groups versus the lower hs-CRP level groups(20.83％,15/72) ; x2 =10.375,P ＜ 0.001by Log-rank].The same as the death rate [9.86％ (7/71) were evaluated in the lower hs-CRP level groups (1.38％,1/72) ;x2 =11.362,P ＜0.05 by Log-rank].The readmission rate and mortality in the patients with hs-CRP ＞3.0 mg/ L are 43.75％ (35/80)and 8.75％ (7/80),respectively.The survival time was all less than 20 months.Conclusions The results demonstrated that hs-CRP is an independent risk factor in cardiovascular disease.High hs-CRP is strongly associated with 5-year occurance of readmission and death for cardiovascular events.Hs-CRP can be a strong indicator of risk stratification and prognostic evaluation on cardiovascular high-risk populations.

Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention)

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

Association of postprocedural neutrophil count and prognosis in ST-elevated myocardial infarction patients after percutaneous coronary intervention

Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention.

A V-shaped association between high-density lipoprotein cholesterol levels and poor outcomes in patients after percutaneous coronary intervention

Effect of hyperhomocysteine in patients after PCI for non-ST-segment elevation myocardial infarction, a retrospective study

[Association of High-Density Lipoprotein Cholesterol with Risk of Cardiovascular Disease Mortality].

A higher non‐HDL‐C/HDL‐C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

Associations of HDL-C and ApoA-I with Mortality Risk in PCI Patients Across Different hsCRP Levels

Association between the proportion of HDL-Cholesterol subclasses and the severity of coronary artery stenosis in patients with Acute Myocardial Infarction

Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study

Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study

Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention

C-reactive Protein and Other Cardiovascular Biomarkers Are Prediction of Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Non-HDL-C, Symptomatic Intracranial Arterial Stenosis, and Recurrent Vascular Risk in Minor Stroke

Lipid-modifying Therapy in Diabetic Patients with High Plasma Non-High-density Lipoprotein Cholesterol after Percutaneous Coronary Intervention.

Non-High-Density Lipoprotein Cholesterol Predicts Adverse Outcomes in Acute Ischemic Stroke.

High-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio predicts long-term adverse outcomes in patients who underwent percutaneous coronary intervention: A prospective cohort study